Stay informed with the latest updates for the inheritable blood disorders community.

Advocacy & Legislative
Additional Resources
Important Changes Coming to Your State Medicaid or CHIP Program
Feb 2, 2023
Medical
DNA Gene Helix
WFH Gene Therapy Registry Goes Live
Jan 31, 2023
Industry
Sanofi Announces New Efanesoctocog alfa Data Published in the NEJM
Jan 30, 2023
Blood Safety
FDA Initiating National Blood Surveillance Monitoring System
NHF Responds to FDA's Proposed Blood Donation Changes
Jan 27, 2023
Advocacy & Legislative
NHF & HFA Respond to New Blue Cross Blue Shield of Tennessee Formularies…
Jan 20, 2023
Industry
Scientist Pipetting Liquids for Research
New FIX Chromogenic Assay Launched by Precision BioLogic
Jan 18, 2023
Industry
Biomarin Provides Hemophilia A Clinical Development Program Updates
Biomarin Provides Hemophilia A Clinical Development Program Updates
Jan 10, 2023
Industry
Takeda Announces Trial Results on Investigational Therapy for Ultra Rare Blood Disorder
Takeda Announces Trial Results on Investigational Therapy for…
Jan 10, 2023
Press Releases
NHF Announces 2023 Winter/Spring Wednesday Webinar Schedule
Jan 5, 2023
Industry
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy
Pfizer Announces Trial Updates for Investigational Hemophilia Gene Therapy…
Jan 4, 2023
Press Releases
PPTA Posts Statement on Monkeypox and Plasma Protein Therapies
NHF Assumes Leadership of the American Plasma Users Coalition
Jan 3, 2023
NHF & Community
Own Your Path
NHF's Own Your Path program begins recruitment
Dec 21, 2022
Industry
Clinical Trial Lab Research
Spark Announces SPK-8011 Updates at ASH
Dec 15, 2022
Press Releases
75th Anniversary
National Hemophilia Foundation Set to Celebrate 75 Years in 2023
Dec 13, 2022
Medical
gene therapy
First Hemophilia B Gene Therapy Approved by FDA
Nov 23, 2022